Search results for "Prostate Cancer"
Internists should follow up with prostate cancer patients receiving ADT
Internists should follow up with prostate cancer patients receiving ADT
https://immattersacp.org/weekly/archives/2010/02/09/5.htm
9 Feb 2010
OTC birth control pill, naloxone gain approval
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023
Docetaxel may prolong prostate cancer survival in patients with metastasis
Docetaxel added to the start of hormone therapy for metastatic prostate cancer may prolong survival compared to patients who received hormone therapy alone, according to early results from a trial.
https://immattersacp.org/weekly/archives/2013/12/17/4.htm
17 Dec 2013
BPH drug may lower prostate cancer incidence, effect on mortality unknown
BPH drug may lower prostate cancer incidence, effect on mortality unknown
https://immattersacp.org/weekly/archives/2010/04/06/4.htm
6 Apr 2010
New guidance urges caution on testosterone
Internists considering testosterone therapy are ideally positioned to consider a broader differential diagnosis that will actually help the patient.
https://immattersacp.org/archives/2020/05/new-guidance-urges-caution-on-testosterone.htm
1 May 2020
Prostate cancer treatment options result in similar 15-year outcomes
Functional outcomes among men undergoing prostatectomy or radiotherapy for prostate cancer differed at two and five years of follow-up, but significant differences were no longer present by 15 years, a study found.
https://immattersacp.org/weekly/archives/2013/02/05/4.htm
5 Feb 2013
Model predicts erectile function after prostate cancer
Researchers have developed a new model to predict the risk of erectile dysfunction for men undergoing prostate cancer treatment.
https://immattersacp.org/weekly/archives/2011/09/27/4.htm
27 Sep 2011
No mortality benefit associated with primary androgen deprivation therapy in localized prostate cancer
Primary androgen deprivation therapy (PADT) yielded no mortality benefit compared with no PADT in men with clinically localized prostate cancer, according to a new study.
https://immattersacp.org/weekly/archives/2014/03/25/5.htm
25 Mar 2014
Low-risk, low-PSA prostate cancer receiving aggressive interventions
Low-risk, low-PSA prostate cancer receiving aggressive interventions
https://immattersacp.org/weekly/archives/2010/08/03/7.htm
3 Aug 2010
In the News
New opioid therapy guidelines released; PFO closure may help migraines.
https://immattersacp.org/archives/2009/04/in-the-news.htm
1 Apr 2009